2,4,6‐Octatrienoic acid is a novel promoter of melanogenesis and antioxidant defence in normal human melanocytes via PPAR‐γ activation
暂无分享,去创建一个
E. Flori | M. Picardo | Y. Ramot | R. Paus | S. Briganti | D. Kovacs | A. Mastrofrancesco | B. Bellei
[1] M. Picardo,et al. Wnt/β‐catenin signaling is stimulated by α‐melanocyte‐stimulating hormone in melanoma and melanocyte cells: implication in cell differentiation , 2011, Pigment cell & melanoma research.
[2] J. Vostálová,et al. Solar radiation induced skin damage: Review of protective and preventive options , 2010, International journal of radiation biology.
[3] A. Ciccodicola,et al. PPARG: Gene Expression Regulation and Next-Generation Sequencing for Unsolved Issues , 2010, PPAR research.
[4] E. Camera,et al. Azelaic acid modulates the inflammatory response in normal human keratinocytes through PPARγ activation , 2010, Experimental dermatology.
[5] P. Webb. Faculty Opinions recommendation of Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5. , 2010 .
[6] Patrick R. Griffin,et al. Obesity-linked phosphorylation of PPARγ by cdk5 is a direct target of the anti-diabetic PPARγ ligands , 2010, Nature.
[7] J. Borovanský,et al. “Transcription physiology” of pigment formation in melanocytes: central role of MITF , 2010, Experimental dermatology.
[8] M. Matsuda,et al. Human catalase gene is regulated by peroxisome proliferator activated receptor-gamma through a response element distinct from that of mouse. , 2010, Endocrine journal.
[9] V. Swope,et al. Stepping up melanocytes to the challenge of UV exposure , 2010, Pigment cell & melanoma research.
[10] C. Bertolotto,et al. Fifteen‐year quest for microphthalmia‐associated transcription factor target genes , 2010, Pigment cell & melanoma research.
[11] A. L. Kadekaro,et al. α‐MSH activates immediate defense responses to UV‐induced oxidative stress in human melanocytes , 2009, Pigment cell & melanoma research.
[12] H. Niida,et al. DNA damage responses in skin biology--implications in tumor prevention and aging acceleration. , 2009, Journal of dermatological science.
[13] T. Luger,et al. Alpha-melanocyte-stimulating hormone counteracts the suppressive effect of UVB on Nrf2 and Nrf-dependent gene expression in human skin. , 2009, Endocrinology.
[14] K. Kubo,et al. Protective effect of beraprost sodium, a stable prostacyclin analog, in the development of cigarette smoke extract-induced emphysema. , 2009, American journal of physiology. Lung cellular and molecular physiology.
[15] R. Paus,et al. The α‐melanocyte stimulating hormone‐related tripeptide K(D)PT stimulates human hair follicle pigmentation in situ under proinflammatory conditions , 2009, The British journal of dermatology.
[16] S. González,et al. The latest on skin photoprotection. , 2008, Clinics in dermatology.
[17] K. Reiss,et al. PPAR γ regulates MITF and β‐catenin expression and promotes a differentiated phenotype in mouse melanoma S91 , 2008, Pigment cell & melanoma research.
[18] V. Hearing,et al. Modifying skin pigmentation - approaches through intrinsic biochemistry and exogenous agents. , 2008, Drug discovery today. Disease mechanisms.
[19] D. Tobin,et al. The silver locus product (Silv/gp100/Pmel17) as a new tool for the analysis of melanosome transfer in human melanocyte–keratinocyte co‐culture , 2008, Experimental dermatology.
[20] J. Plutzky,et al. Retinoid metabolism and nuclear receptor responses: New insights into coordinated regulation of the PPAR–RXR complex , 2008, FEBS letters.
[21] E. Flori,et al. Correlation between melanogenic and catalase activity in in vitro human melanocytes: a synergic strategy against oxidative stress , 2007, Pigment cell & melanoma research.
[22] D. Tobin,et al. Dissecting the impact of chemotherapy on the human hair follicle: a pragmatic in vitro assay for studying the pathogenesis and potential management of hair follicle dystrophy. , 2007, The American journal of pathology.
[23] H. Kang,et al. PPAR‐gamma agonist, ciglitazone, increases pigmentation and migration of human melanocytes , 2007, Experimental dermatology.
[24] R. Paus,et al. Towards the development of a simplified long‐term organ culture method for human scalp skin and its appendages under serum‐free conditions , 2007, Experimental dermatology.
[25] E. Steingrímsson,et al. The Microphthalmia-Associated Transcription Factor Mitf Interacts with β-Catenin To Determine Target Gene Expression , 2006, Molecular and Cellular Biology.
[26] D. Fisher,et al. Topical drug rescue strategy and skin protection based on the role of Mc1r in UV-induced tanning , 2006, Nature.
[27] S. Farmer,et al. Functional Interaction between Peroxisome Proliferator-Activated Receptor γ and β-Catenin , 2006, Molecular and Cellular Biology.
[28] K. McGraw,et al. Distribution of unique red feather pigments in parrots , 2005, Biology Letters.
[29] D. Bishop,et al. The genetics of susceptibility to cutaneous melanoma. , 2005, Drugs of today.
[30] Guido Steiner,et al. beta-Carotene interferes with ultraviolet light A-induced gene expression by multiple pathways. , 2005, The Journal of investigative dermatology.
[31] Juan J. Negro,et al. The Evolution of bird plumage colouration: a role for feather-degradation bacteria? , 2004 .
[32] D. Tobin,et al. Melanin pigmentation in mammalian skin and its hormonal regulation. , 2004, Physiological reviews.
[33] K. McGraw,et al. Carotenoid pigments and the selectivity of psittacofulvin-based coloration systems in parrots. , 2004, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.
[34] M. Danilenko,et al. Carotenoids activate the antioxidant response element transcription system. , 2004, Molecular cancer therapeutics.
[35] H. Y. Kang,et al. Expression and function of peroxisome proliferator‐activated receptors in human melanocytes , 2004, The British journal of dermatology.
[36] F. Domann,et al. Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter. , 2002, Molecular endocrinology.
[37] T. Willson,et al. Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. , 2002, Biochemistry.
[38] J. Auwerx,et al. A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity. , 2001, Molecular cell.
[39] V. Virador,et al. Effects of all-trans retinoic acid on melanogenesis in pigmented skin equivalents and monolayer culture of melanocytes. , 2001, Journal of dermatological science.
[40] G. Celentano,et al. The chemical structure of the pigments in Ara macao plumage. , 2001, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.
[41] L. Freedman,et al. Discrete Roles for Peroxisome Proliferator-Activated Receptor γ and Retinoid X Receptor in Recruiting Nuclear Receptor Coactivators , 2000, Molecular and Cellular Biology.
[42] Kazuhiro Takahashi,et al. Induction of Melanocyte-specific Microphthalmia-associated Transcription Factor by Wnt-3a* , 2000, The Journal of Biological Chemistry.
[43] R. Mason,et al. Topical all-trans retinoic acid augments ultraviolet radiation-induced increases in activated melanocyte numbers in mice. , 1999, The Journal of investigative dermatology.
[44] K. Bille,et al. Regulation of tyrosinase gene expression by cAMP in B16 melanoma cells involves two CATGTG motifs surrounding the TATA box: implication of the microphthalmia gene product , 1996, The Journal of cell biology.
[45] J J Strain,et al. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. , 1996, Analytical biochemistry.
[46] G. Halliday,et al. Topical retinoic acid augments ultraviolet light‐induced melanogenesis , 1992, Melanoma research.
[47] I. Buño,et al. Disparate antioxidant enzyme activities in cultured human cutaneous fibroblasts, keratinocytes, and melanocytes. , 1991, The Journal of investigative dermatology.
[48] C. Bertolotto,et al. Ciglitazone negatively regulates CXCL1 signaling through MITF to suppress melanoma growth , 2011, Cell Death and Differentiation.
[49] U. Osterwalder,et al. Photoprotection: a Review of the Current and Future Technologies , 2010, Dermatologic therapy.
[50] J. Wood,et al. UVA-irradiated pheomelanin alters the structure of catalase and decreases its activity in human skin. , 2006, The Journal of investigative dermatology.
[51] Hong Wang,et al. Functional interaction between peroxisome proliferator-activated receptor gamma and beta-catenin. , 2006, Molecular and cellular biology.
[52] R. Paus,et al. Interferon-gamma is a potent inducer of catagen-like changes in cultured human anagen hair follicles. , 2005, The British journal of dermatology.
[53] J. J. Negro,et al. THE EVOLUTION OF BIRD PLUMAGE COLOURATION : A ROLE FOR FEATHER-DEGRADING BARCTERIA ? , 2005 .
[54] M. Falchi,et al. Biological activity of parrodienes, a new class of polyunsaturated linear aldehydes similar to carotenoids. , 2004, Drugs under experimental and clinical research.
[55] S. Pinnell. Cutaneous photodamage, oxidative stress, and topical antioxidant protection. , 2003, Journal of the American Academy of Dermatology.
[56] M. Falchi,et al. Evaluation of the antioxidant activity of new carotenoid-like compounds by electron paramagnetic resonance. , 2003, Drugs under experimental and clinical research.
[57] 渡部 秀憲. All-trans retinoic acid induces differentiation and apoptosis of murine melanocyte precursors with induction of the microphthalmia-associated transcription factor , 2003 .